Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Indiva Ltd NDVAF


Primary Symbol: V.NDVA

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of... see more

TSXV:NDVA - Post Discussion

Indiva Ltd > Outlook for 2024
View:
Post by Duster340 on Apr 25, 2024 9:01am

Outlook for 2024

i am thinking once tilray gets things turned around they also could be the company that buys out ndva mr simon likes to make aquisitions marijuanna, kraft beer why not edibles ndva already does business with them. ( Indiva began supplying Tilray Brands, Inc.'s ("Tilray") medical platform with Indiva products. Products are now available to Tilray medical patients including Pearls by Grn, Wana Sour Gummies, Bhang Chocolate as well as Doppio Sandwich Cookies.)



For the fiscal year 2024, the Company expects to generate record net revenue and record EBITDA, driven by continued strength in its core brands, bolstered by new product introductions and continued efficiency gains at the production facility from automation and process improvements. 
Comment by caretired1 on Apr 25, 2024 9:16am
Yah and with Health Cda not meddling like they did with lozenges, Gron and No Future selling for a full year
Comment by nedstar71 on Apr 27, 2024 12:19am
These guys are really hitting it out of the park operation wise.  It's amazing what they've been able to do, more than replacing Wana revenue and at the same time displacing Wana as the top selling edible.  Talk about executing well. It's a shame the industry is what it is and  nobody has been able to figure out how to make a decent profit.   Hopefully that ...more  
Comment by caretired1 on Apr 27, 2024 8:53am
If I was Canopy, I would buy Indiva, especially now that the CGC stock has some currency again. They would keep all the Wana margin in Canada and make expansion into Michigan, Ohio, New York easier with the great team in London providing all of the intellect and operations expertise.
Comment by Duster340 on Apr 30, 2024 2:17pm
Or tilray when legalized in the us tilray is already set-up for business. i think our value as a takeover candidate has gone up with the DEA anounncment today, safe banking next, then legalization. multiple buyers? flush with cash.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities